Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes
Clinical trial NCT02054897 · COMPLETED
Trial details
- NCT number
- NCT02054897
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-03
- Primary completion
- 2015-05-08
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.